Showing 1511-1520 of 20878 results for "".
- Isotretinoin Slows Growth Rate in Teens, But Final Height Unchangedhttps://reachmd.com/news/isotretinoin-slows-growth-rate-in-teens-but-final-height-unchanged/2484962/Adolescents treated with isotretinoin for acne may experience temporary reductions in height velocity, but the medication does not appear to impact final adult height, according to a new retrospective cohort study published in the
- Most Insurers Cover Botulinum Toxin for Axillary Hyperhidrosis: Analysishttps://reachmd.com/news/most-insurers-cover-botulinum-toxin-for-axillary-hyperhidrosis-analysis/2484933/A new cross-sectional study published in the Journal of Drugs in Dermatology finds that while botulinum toxin is broadly covered by private insurers for the treatment of primary axillary hyperhidrosis, access barriers due to
- Evaluating Targeted Therapies for Inflammatory Skin Diseases: A Focus on Baricitinib in Lichen Planushttps://reachmd.com/news/evaluating-targeted-therapies-for-inflammatory-skin-diseases-a-focus-on-baricitinib-in-lichen-planus/2484952/Mayo Clinic investigators show that baricitinib produces rapid clinical benefit in liche
- Reframing MASLD: Oxygen-Nutrient Imbalance as a Key Driver of Diseasehttps://reachmd.com/news/masld-oxygen-nutrient-imbalance/2484916/In a new review, researchers reframe metabolic dysfunction-associated steatotic liver disease (MASLD) as a supply-demand injury in which excess portal caloric delivery can outpace hepatic oxyge
- Neonatal Outcomes in Preterm Infants by Gestational Age: Insights from a Retrospective Cohort Studyhttps://reachmd.com/news/neonatal-outcomes-preterm-infants-gestational-age/2484917/A recent cohort study provides new data on short-term neonatal outcomes across late‑preterm, early‑term, and full‑term births, quantifying risks that inform timing of elective delivery.
- Regulatory Milestones for the Holly Implantable Dialysis System: A New Era in Renal Replacement Technologyhttps://reachmd.com/news/holly-implantable-dialysis-renal-replacement/2484925/The Holly implantable dialysis system has received FDA Breakthrough Device de
- Decoding Fetal Microcephaly: Genetic Insights from a Recent Prenatal Cohort Studyhttps://reachmd.com/news/fetal-microcephaly-genetic-prenatal-cohort/2484924/In a prenatal cohort, researchers found marked genotypic and phenotypic heterogeneity among fetuses with clinically identified microcephaly. In 197 fetuses referred fo
- AAFPRS Issues Alert Regarding Rise of Counterfeit Neuromodulatorshttps://reachmd.com/news/aafprs-issues-alert-regarding-rise-of-counterfeit-neuromodulators/2484932/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released a warning to consumers to remain vigilant as counterfeit and unapproved neuromodulators continue to enter the aesthetic medicine market. The AAFPRS issued the warning after the US Food and Drug Administration
- Prolonged Sitting and Cardiovascular Risks in Older Adults: Insights and Interventionshttps://reachmd.com/news/prolonged-sitting-and-cardiovascular-risks-in-older-adults-insights-and-interventions/2484892/A global review links prolonged sitting in adults aged 60 and older to marked increases in cardiometabolic harm — hi
- Pioneering Renal Assist Device: JuxtaFlow's Initial Successhttps://reachmd.com/news/pioneering-renal-assist-device-juxtaflows-initial-success/2484903/JuxtaFlow Renal Assist Device showed promising physiologic decongestion in the first‑in‑human VOID‑HF trial, increasing 24‑hour urine output and sodium excretion in patients with diuretic resistance. The